Table 1 Data of patients with available serology for HEV, HAV and PVB19.

From: Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitis

 

total

anti-HEV

anti-HAV

anti-PVB19

untreated AIH

untreated AIH

non-AIH liver disease

untreated AIH

local pediatric control

DEGS1 study*

untreated AIH pediatric

local pediatric control

pediatric

adult

pediatric

adult

pediatric

adult

Numbers

219

25

80

8

314

56

135

87

6585

31

33

female gender (%)

72%

76%

65%

25%

52%

75%

69%

44%

53%

84%

52%

age (median (IQR) in years)

40.5 (42.9)

14.7 (3.4)

49.9 (24.1)

13.3 (4.8)

50.5 (21.7)

13.0 (6.1)

53.2 (22.5)

12.7 (5.0)

n.d.

12.9 (4.3)

12.0 (6.4)

Age distribution

0–17

71

25

 

8

 

56

 

87

 

31

33

18–39

36

 

22

 

88

 

33

 

1692

  

40–59

60

 

34

 

146

 

54

 

2509

  

>/=60

52

 

24

 

80

 

48

 

2384

  
  1. *Unadjusted numbers from DEGS1 study14,43; n.d.: not determined.
Back to article page